Reference
Health Canada. Summary Safety Review - Remicade (infliximab), Humira (adalimumab), Enbrel (etanercept) and Erelzi (biosimilar etanercept) - Health Canada. Internet Document : 18 Mar 2021. Available from: URL: https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&linkID=SSR00260
Rights and permissions
About this article
Cite this article
TNF-alpha inhibitors: potential risk of mycosis fungoides. Reactions Weekly 1849, 7 (2021). https://doi.org/10.1007/s40278-021-93391-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-93391-1